Fig. 5From: Clinical impact of removing respiratory motion during liver SABRThe relationship between dose escalation using the motion managed PTV, as a function of PTV reduction as a percentage of the ITV-based PTV (part (a)) and the motion vector magnitude of the GTV (part (b))Back to article page